Literature DB >> 19278741

The prognostic value of biomarkers after a premature myocardial infarction.

Javier Pineda1, Francisco Marín, Pascual Marco, Vanessa Roldán, José Valencia, Juan Miguel Ruiz-Nodar, Diana Hernández Romero, Francisco Sogorb, Gregory Y H Lip.   

Abstract

BACKGROUND: Intravascular thrombogenesis is influenced by a complex interplay of factors related to a procoagulant state, fibrinolysis, endothelial damage/dysfunction and inflammation. We hypothesised that abnormalities of these biological systems would contribute to outcome of coronary artery disease presenting at a young age.
METHODS: We performed a prospective study of 142 subjects presenting with acute myocardial infarction (AMI) at a young age (defined as age ≤45 years), to determine the clinical and laboratory predictors of cardiovascular events during 36 months of follow-up. We assessed conventional risk factors and abnormalities of thrombophilia [total homocysteine (tHcy), lipoprotein (a) [Lp(a)], antiphospholipid antibodies (APA)], as well as lipid profile (total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides), fibrinogen and fibrin D-dimer (as indices of a hypercoagulable state and thrombogenesis), von Willebrand factor (vWF, an index of endothelial damage/dysfunction), tissue plasminogen activator [t-PA antigen] and its inhibitor [PAI-1 antigen] (as indices of fibrinolysis), and C-reactive protein [CRP] (an index of inflammation).
RESULTS: In a multivariate analysis, the variables independently associated with cardiovascular events at follow-up were levels of homocysteine (OR 3.73, 95% CI (1.54-9.02); p=0.003), left ventricle systolic dysfunction (OR 3.04, 95% CI (1.00-9.25); p=0.050), and smoking habit (OR 2.79, 95% CI (1.09-7.14) p=0.032).
CONCLUSIONS: Prognostic markers associated with cardiovascular events in premature CAD (young AMI subjects) were cigarette smoking and EF<50% of left ventricle as conventional clinical risk factors, as well as higher levels of homocysteine.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19278741     DOI: 10.1016/j.ijcard.2009.02.019

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

Review 1.  Coronary heart disease in young adults.

Authors:  Jessica B Rubin; William B Borden
Journal:  Curr Atheroscler Rep       Date:  2012-04       Impact factor: 5.113

2.  Prognostic Value of D-dimer in patients with acute coronary syndrome treated by percutaneous coronary intervention: a retrospective cohort study.

Authors:  Runzhen Chen; Chen Liu; Peng Zhou; Yu Tan; Zhaoxue Sheng; Jiannan Li; Jinying Zhou; Yi Chen; Li Song; Hanjun Zhao; Hongbing Yan
Journal:  Thromb J       Date:  2021-05-07

3.  Disparity in risk factor pattern in premature versus late-onset coronary artery disease: a survey of 15,381 patients.

Authors:  Rona Reibis; Andras Treszl; Karl Wegscheider; Kurt Bestehorn; Barbara Karmann; Heinz Völler
Journal:  Vasc Health Risk Manag       Date:  2012-08-17

4.  Prognostic Value of Age-Adjusted D-Dimer Cutoff Thresholds in Patients with Acute Coronary Syndrome Treated by Percutaneous Coronary Intervention.

Authors:  Runzhen Chen; Chen Liu; Peng Zhou; Jiannan Li; Jinying Zhou; Ruoqi Song; Weida Liu; Yi Chen; Li Song; Hanjun Zhao; Hongbing Yan
Journal:  Clin Interv Aging       Date:  2022-02-09       Impact factor: 4.458

Review 5.  Prevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in Spain.

Authors:  Alex de la Sierra; Xavier Pintó; Carlos Guijarro; José López Miranda; Daniel Callejo; Jesús Cuervo; Rudi Subirà; Marta Rubio
Journal:  Adv Ther       Date:  2015-10-26       Impact factor: 3.845

Review 6.  Lipoprotein(a)-The Crossroads of Atherosclerosis, Atherothrombosis and Inflammation.

Authors:  Sabina Ugovšek; Miran Šebeštjen
Journal:  Biomolecules       Date:  2021-12-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.